INTRADERMAL HPV PEPTIDE VACCINATION

摘要

PROBLEM TO BE SOLVED: To provide an improved HPV vaccine which does not have any fault of an existing vaccine at all, especially to provide an HPV vaccine used in the invention which does not require a high-dose peptide and/or continuous vaccination and/or adjuvant.SOLUTION: The invention relates to the use of a peptide derived from HPV-E2, -E6 and/or E7 protein for the manufacture of a medicament for the treatment or prevention of an HPV related disease, wherein the medicament is for intradermal administration.